<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    How does MRNA's Q3 2024 EPS compare to industry peers?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        4/11/2025 05:28pm
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Moderna's (MRNA) Q3 2024 EPS of $0.03 was significantly lower than its industry peers, Pfizer (PFE), Biomarin (BMRN), and AbCellera Biologics (ABCL), with PFE's EPS of $0.78, BMRN's EPS of $0.55, and ABCL's EPS of -$0.17:


|code|Ticker|Name|Date|Diluted EPS|market_code|
|---|---|---|---|---|---|
|MRNA|MRNA.O|Moderna|2024 Q1|-3.07|185|
|ABCL|ABCL.O|AbCellera Biologics|2024 Q1|-0.14|185|
|PFE|PFE.N|Pfizer|2024 Q1|0.55|169|
|BMRN|BMRN.O|Biomarin|2024 Q1|0.46|185|
|MRNA|MRNA.O|Moderna|2024 Q2|-3.33|185|
|ABCL|ABCL.O|AbCellera Biologics|2024 Q2|-0.13|185|
|PFE|PFE.N|Pfizer|2024 Q2|0.01|169|
|BMRN|BMRN.O|Biomarin|2024 Q2|0.55|185|
|MRNA|MRNA.O|Moderna|2024 Q3|0.03|185|
|ABCL|ABCL.O|AbCellera Biologics|2024 Q3|-0.17|185|

</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al,am,an,ao,ap,aq,ar,as,at,au,av,aw,ax,ay,az,aA,aB,aC,aD,aE,aF,aG,aH,aI,aJ,aK,aL){return {layout:"default",data:[{noData:c,currentQuestion:h,textDescription:af,comeFrom:"AInvestShareLink",events:[],answerSource:o}],fetch:{},error:p,state:{sharePreviewModule:{loadJgySuccess:f,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:R,agent_id:a,output_media_info:[],task_id:a,language:a,source:o,cache_builder:a,reply_action:"Answer",execute_mode:S,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"How does MRNA's Q3 2024 EPS compare to industry peers?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"How does MRNA's Q3 2024 EPS compare to industry peers?\",\"user_id\":\"dp55041746\",\"user_name\":\"\",\"trace_id\":\"c1346fe1-276e-4aa9-b9d1-717a1982ac18\",\"session_id\":\"c1346fe1-276e-4aa9-b9d1-717a1982ac18\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"query_data",query_type:l,text:"4 results found:\n|stock code|stock name|Last Price|Last Change|Diluted EPS[20240930]|Report End Date|\n|---|---|---|---|---|---|\n|PFE|Pfizer|$21.59|-4%|$0.78|20240929|\n|BMRN|Biomarin|$56.32|-5.23%|$0.55|20240930|\n|MRNA|Moderna|$24.5|-8.14%|$0.03|20240930|\n|ABCL|AbCellera Biologics|$2.07|-4.61%|-$0.17|20240930|\n",query_data:{number:ag,title:T,query_type:l,condition:a,model_sql:ah,data_ext_params:{merge_repeat:c,expand_index:b,data_add:R,add_index:f}}}],answer_chain_name:ai,agent_mode:aj,native_answer:a,come_from:a,text_answer:af,trace_id:j,cost:20318,event_names:a,question:h,fallback_type:ak,input_type:al,fall_back_reason:{fall_back_type:ak,risk_detail:{matched_words:[]}},session_id:j,first_return_cost:2572,cache_type:a,question_id:j,transfer_question:h,signal_type:"ON_COMPLETE",start_time:am,remote_svc:o,slots:[],answer_type:S,user_id:C,skill_name:U},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:j,session_id:j,user_id:C,question:h,source:o,raw_question:h,version:"3.4.1",action_name:U,nlu:{entity:[{type:q,value:D,market:d}]},deep_research:c,deep_thinking:c,agent_mode:aj},extra:{}},{answer_path:r,section:{id:s,info_texts:["Thinking"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"begin"},logs:[],extra:{is_deep_research:c,deep_thinking:c}},{answer_path:r,section:{id:s,info_texts:["Querying Stock: MRNA GICS Industry"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:an},logs:[],extra:{action:ao,action_input:"MRNA GICS Industry",thought:"The user wants to compare MRNA's Q3 2024 EPS with its industry peers. I should focus on identifying key competitors and gathering EPS data. I will use FinQuery to identify MRNA's industry. Then, I will use FinQuery to obtain EPS data for MRNA and its identified competitors."}},{answer_path:e,section:{id:m,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:r,section:{id:s,info_texts:["Querying Stock: MRNA, PFE, BMRN, ABCL EPS in 2024Q3"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:an},logs:[],extra:{action:ao,action_input:T,thought:"I have identified MRNA's industry as Biotechnology. Now I will use FinQuery to obtain EPS data for MRNA and its competitors."}},{answer_path:e,section:{id:m,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:m,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:r,section:{id:s,info_texts:["Generating Answer"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"ongoing"},logs:[],extra:{}},{answer_path:e,section:{id:i,info_texts:[],show_type:E,voice_txt:"Mod",text_answer:ap,rich_text:ap,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:2000,info_texts:[],show_type:E,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{title:T,query_type:l,trace_data:a,index:ag,model_sql:ah,data_ext_params:{merge_repeat:c,expand_index:b,data_add:R,add_index:f},jump_type:"data_query"}],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:m,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:m,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:m,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:i,info_texts:[],show_type:E,voice_txt:":\n\n",text_answer:aq,rich_text:aq,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:F,market_id:d,name:u,domain:q},pos:f,section_id:i,txt:u,jump_type:G},{stock_info:{code:H,market_id:I,name:v,domain:q},pos:87,section_id:i,txt:v,jump_type:G},{stock_info:{code:J,market_id:d,name:w,domain:q},pos:101,section_id:i,txt:w,jump_type:G},{stock_info:{code:K,market_id:d,name:x,domain:q},pos:122,section_id:i,txt:x,jump_type:G}],is_last:b},logs:[],extra:{}},{answer_path:e,section:{id:i,info_texts:[],show_type:ar,choice:[],result_page:{components:[{uuid:"2415cfad6f932755",config:{score:116,show_type:as,scoreRuleNames:"value_unit;data_size;",showDataZoom:b,show_type_id:133,title:"分组柱状图",render:{t:L,x:y,y:[M]},title_config:{config:{display:b,display2:c,txt_style:f,url:a},data:{h1:at,h2:a},show_type:V}},data:{chunks_info:"[]",code_count:au,columns:[{index_name:L,key:L,label:"hq_code",source:W,type:g},{domain:X,feKey:Y,index_name:Y,key:Y,label:L,origin_index:"stock code",source:W,type:g,unit:a},{domain:X,feKey:Z,index_name:Z,key:Z,label:"name",origin_index:"stock name",source:W,type:g,unit:a},{feKey:y,index_name:y,key:y,label:"date",origin_index:y,type:"DATE"},{domain:X,feKey:M,index_name:M,key:M,label:a,source:a,timestamp:a,type:"DOUBLE",unit:"USD"},{index_name:av,key:av,type:g}],condition:"[{\"sonSize\":2,\"opName\":\"and\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@stock code\",\"indexProperties\":[\"EQUAL MRNA.O\\u003e-\\u003cABCL.O\\u003e-\\u003cPFE.N\\u003e-\\u003cBMRN.O\"],\"indexPropertiesMap\":{\"EQUAL\":\"MRNA.O\\u003e-\\u003cABCL.O\\u003e-\\u003cPFE.N\\u003e-\\u003cBMRN.O\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0},{\"sonSize\":0,\"indexName\":\"国际美股@Diluted EPS\",\"indexProperties\":[\"起始交易日期 20240101\",\"截止交易日期 20240930\"],\"indexPropertiesMap\":{\"起始交易日期\":\"20240101\",\"截止交易日期\":\"20240930\"},\"domain\":\"abs_国际美股领域\",\"relatedSize\":0}]",dataSize:12,datas:[{code:F,Ticker:D,"Diluted EPS":-3.07,market_code:d,Date:N,Name:u},{code:K,Ticker:_,"Diluted EPS":-.14,market_code:d,Date:N,Name:x},{code:H,Ticker:$,"Diluted EPS":aa,market_code:I,Date:N,Name:v},{code:J,Ticker:ab,"Diluted EPS":.46,market_code:d,Date:N,Name:w},{code:F,Ticker:D,"Diluted EPS":-3.33,market_code:d,Date:O,Name:u},{code:K,Ticker:_,"Diluted EPS":-.13,market_code:d,Date:O,Name:x},{code:H,Ticker:$,"Diluted EPS":.01,market_code:I,Date:O,Name:v},{code:J,Ticker:ab,"Diluted EPS":aa,market_code:d,Date:O,Name:w},{code:F,Ticker:D,"Diluted EPS":.03,market_code:d,Date:P,Name:u},{code:K,Ticker:_,"Diluted EPS":-.17,market_code:d,Date:P,Name:x},{code:H,Ticker:$,"Diluted EPS":.78,market_code:I,Date:P,Name:v},{code:J,Ticker:ab,"Diluted EPS":aa,market_code:d,Date:P,Name:w}],meta:{extra:{}},row_count:au,status_code:f,status_msg:"ok"},category:"generic",chart_type:"groupedBar",show_type:as,title_config:{config:{display:b,display2:c,txt_style:f,url:a},data:{h1:at,h2:a},show_type:V},support_refresh:b,data_config:{query:a,query_type:l,data_ext_params:{}}}],global:{query_type:l},page:{language:a,layout:{layout_data:"[{\"children\":[],\"showType\":\"bar3\",\"uuid\":\"2415cfad6f932755\"}]"},render_for:ac},data_config:{query:a,query_type:l,data_ext_params:{}}},tag_info_list:[],is_last:c,uuid:"d2854934-05ed-45dc-9c7a-3ec2584ba3ea"},logs:[],extra:{}},{answer_path:e,section:{id:i,info_texts:[],show_type:E,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:r,section:{id:s,info_texts:["Completed"],show_type:t,choice:[],result_page:{},tag_info_list:[],is_last:b,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:ar,choice:[{display_text:z,query_text:z,trace_info:{item_id:"e789a07571f55532d401b24a33d37c03",item_type:n,item_name:z,rec_info:aw}},{display_text:A,query_text:A,trace_info:{item_id:"b6231c3c10c231bce482dce59ec4632f",item_type:n,item_name:A,rec_info:ax}},{display_text:B,query_text:B,trace_info:{item_id:"d5e6bb816b25be936b2060e72d02c8ac",item_type:n,item_name:B,rec_info:ay}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:V,data:{h1:a,h2:a},config:{display:c,txt_style:f,type:"1",display2:c,url:a}},request_config:[{source_type:az,related_name:aA}],puuid:ad,tag:a,category:"custom",uuid:aB}],global:{urp_static_data:[{name:aA,value:{status_code:f,columns:[{type:g,index_name:aC,key:aC},{type:g,index_name:aD,key:aD},{type:g,index_name:aE,key:aE},{type:g,index_name:aF,key:aF},{type:g,index_name:aG,key:aG}],datas:[{send_text:z,item_type:n,rec_info:aw,display_text:z,rec_reason:a},{send_text:A,item_type:n,rec_info:ax,display_text:A,rec_reason:a},{send_text:B,item_type:n,rec_info:ay,display_text:B,rec_reason:a}],dataSize:az,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:c,visible:b,childLimit:9999,label:aH,type:"thslc\u002Fthslc-common-container",leaf:c,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:b,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:Q,"min-height":"100%",position:aI,height:Q},isMaterial:c,id:aH,needTheme:c,hasEditor:c,packed:c,events:[],child:[{readmeUrl:"https:",stack:c,visible:b,customStyle:a,childLimit:f,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:b,version:"1.12.0",animate:[],url:ae,componentUuid:aB,script:[{name:aJ,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:b,renderType:"blue"},path:ae,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:ae},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:Q,position:aI,height:Q},isMaterial:b,_id:19,id:aJ,hasEditor:b,packed:c,events:[],isSetDefaultValue:b}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:ac,voice_txt:a,tracking_info:{},uuid:ad},order:{is_auto:c,render_for:ac,chart_type:"command",puuid:ad}},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1005,info_texts:[],show_type:k,choice:[],result_page:{},tag_info_list:[],is_last:b},logs:[],extra:{action_name:U,with_paid_index:c,no_refresh_answer:c,answer_source:{agent_id:a,agent_name:a,execute_mode:S,answer_chain_name:ai},is_deep_research:c,deep_thinking:c,create_time:1744363735895},is_last:b}],questionItem:{data:{qStr:h,encodeFlag:c,imageData:p,docsData:[],quoteData:p},tplType:"question"},events:aK,agentId:a,param:{entity_info:{},add_info:{ori_question:h},event_list:aK,client_ip:a,question:h,user_id:C,user_name:a,trace_id:j,session_id:j,source:o,input_type:al}}],userId:C,userName:a,startTime:am,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:p,endSignal:c,theme:"white",showTracePopup:c,traceListData:[],chatTraceTargetIndex:f,traceTableData:p,showMask:c}},serverRendered:b,routePath:"\u002Faime\u002Fshare\u002Fhow-does-mrnas-q3-2024-eps-compare-to-industry-peers-baae36\u002F",config:{_app:{basePath:aL,assetsPath:aL,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",true,false,"185","other\u002FopenAnswer",0,"STR","How does MRNA's Q3 2024 EPS compare to industry peers?",2001,"c1346fe1-276e-4aa9-b9d1-717a1982ac18","signal","intusstock",999,"llm_generated","ths_ainvest_lite_web",null,"stock","progress\u002Fsearching_for",1000,"searching_for","Moderna","Pfizer","Biomarin","AbCellera Biologics","Date","📰 What are the expected EPS for MRNA's Q3 2024?","📊 How do MRNA's Q3 2024 EPS compare to analysts' forecasts?","🤝 How do MRNA's financial ratios compare to those of its industry peers?","dp55041746","MRNA.O","rich_text","MRNA","pos_fenshi","PFE","169","BMRN","ABCL","code","Diluted EPS","2024 Q1","2024 Q2","2024 Q3","auto",1,"agent","MRNA, PFE, BMRN, ABCL EPS in 2024Q3","review stocks","title1","fixed_index","abs_国际美股领域","Ticker","Name","ABCL.O","PFE.N",.55,"BMRN.O","aigc","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Moderna's (MRNA) Q3 2024 EPS of $0.03 was significantly lower than its industry peers, Pfizer (PFE), Biomarin (BMRN), and AbCellera Biologics (ABCL), with PFE's EPS of $0.78, BMRN's EPS of $0.55, and ABCL's EPS of -$0.17:\n\n\n|code|Ticker|Name|Date|Diluted EPS|market_code|\n|---|---|---|---|---|---|\n|MRNA|MRNA.O|Moderna|2024 Q1|-3.07|185|\n|ABCL|ABCL.O|AbCellera Biologics|2024 Q1|-0.14|185|\n|PFE|PFE.N|Pfizer|2024 Q1|0.55|169|\n|BMRN|BMRN.O|Biomarin|2024 Q1|0.46|185|\n|MRNA|MRNA.O|Moderna|2024 Q2|-3.33|185|\n|ABCL|ABCL.O|AbCellera Biologics|2024 Q2|-0.13|185|\n|PFE|PFE.N|Pfizer|2024 Q2|0.01|169|\n|BMRN|BMRN.O|Biomarin|2024 Q2|0.55|185|\n|MRNA|MRNA.O|Moderna|2024 Q3|0.03|185|\n|ABCL|ABCL.O|AbCellera Biologics|2024 Q3|-0.17|185|\n\n",2,"select   stock_code,   diluted_eps from   ustock_fin_data where   report_end_date = date('2024y3q')   and stock_code in ('MRNA.O', 'PFE.N', 'BMRN.O', 'ABCL.O')","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite",1744363715577,"thinking","Querying Stock","Moderna's (MRNA) Q3 2024 EPS of $0.03 was significantly lower than its industry peers, Pfizer (PFE), Biomarin (BMRN), and AbCellera Biologics (ABCL), with PFE's EPS of $0.78, BMRN's EPS of $0.55, and ABCL's EPS of -$0.17[^2]",":\n\n\n``` visual\n{\"uuid\":\"d2854934-05ed-45dc-9c7a-3ec2584ba3ea\"}\n```","result_page","bar3","MRNA, ABCL, PFE, BMRN Diluted EPS",4,"market_code","2+679_496_21_554+0+0+c1346fe1-276e-4aa9-b9d1-717a1982ac18+e789a07571f55532d401b24a33d37c03+llm_generated+aimeTagAnalysis+0+0.09684315323829651+1","2+679_496_21_554+0+0+c1346fe1-276e-4aa9-b9d1-717a1982ac18+b6231c3c10c231bce482dce59ec4632f+llm_generated+aimeTagAnalysis+0+0.0649789571762085+2","2+679_496_21_554+0+0+c1346fe1-276e-4aa9-b9d1-717a1982ac18+d5e6bb816b25be936b2060e72d02c8ac+llm_generated+aimeTagAnalysis+0+0.04033141955733299+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>